Viral induced demyelination

Brain Pathology

Volumn 11, Issue 1, 2001, Pages 92-106

  Stohlman, Stephen A ^a   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY RESPONSE; CENTRAL NERVOUS SYSTEM INFECTION; CONFERENCE PAPER; DEMYELINATING DISEASE; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SUBACUTE SCLEROSING PANENCEPHALITIS; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0035198755     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2001.tb00384.x     Document Type: Conference Paper

References (123)

1. Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA
2. A murine hepatitis virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology
3. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of diseases. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE
4. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis
5. Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat
6. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the CNS
7. Axonal pathology in myelin disorders
8. Cell death during autoimmune demyelination: Effector but not target cells are eliminated by apoptosis
9. The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice
10. Sur un cas d'encephalite subaigue a inclusions. Etude anatomoclinique et ultrastructurale
11. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity
12. Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line
13. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin
14. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues
15. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs
16. Human papovavirus infection in renal allograft recipients
17. Measles-virus antibody and antigen in subacute sclerosing panencephalitis
18. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus
19. Cellular inclusions in cerebral lesions of lethargic encephalitis
20. Primary demyelination in Theiler's virus infection. An ultrastructural study
21. An early, abundant cytotoxic T lymphocyte response against Theiler's virus is critical for preventing viral persistence
22. Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis
23. Opportunistic infections of the central nervous system during AIDS
24. Experimental neuropathology of remote infection with a JHM virus variant (DS)
25. Theiler's virus infection of beta 2-microglobulin-deficient mice
26. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies
27. Interaction of immune and central nervous systems: Contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM
28. Alterations in expression of measles virus polypeptides by antibody: Molecular events in antibody-induced antigenic modulation
29. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
30. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein
31. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope
32. Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: Involvement of microglial cells
33. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells
34. The role of antibody in recovery from alphavirus encephalitis
35. Measles and SSPE virus proteins: Lack of antibodies to the M protein in patients with subacute sclerosing paenencephalitis
36. Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute panencephalitis
37. Measles virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis
38. Involvement of the central nervous system in acute, uncomplicated measles virus infection
39. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination
40. Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leucoencephalopathy
41. Light and electron microscopy observations in the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis)
42. Mouse hepatitis virus-induced recurrent demyelination
43. Regeneration of oligodendroglia during recovery from demyelinating disease
44. T lymphocyte entry into the central nervous system
45. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis
46. Subacute sclerosing panencephalitis: Isolation of a measles virus from a brain biopsy
47. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host
48. Numerous glial fibrillary tangles in oligodendroglia in cases of subacute sclerosing panencephalitis with neurofibrillary tangles
49. Subacute sclerosing panencephalitis. Immunoultrastructural localization of measles-virus antigen
50. Immune mechanisms of Theiler's virus induced demyelination
51. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4
52. Antigen-dependent intrathecal synthesis in the normal rat brain: Tissue entry and local retention of antigen-specific B cells
53. Epidemiologic evidence for multiple sclerosis as an infection
54. Induction of self-reactive T cells after murine infection
55. Mechanism of demyelination in JHM virus encephalomyelitis
56. Experimental demyelination produced by the A59 strain of mouse hepatitis virus
57. Antibody-induced restriction of viral gene expression in measles encephalitis in rats
58. Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis
59. The role of IL-10 in mouse hepatitis virus-induced encephalomyelitis
60. Antibody prevents virus reactivation within the central nervous system
61. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination
62. Role of viral persistence in retaining CD8+ T cells within the central nervous system
63. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurological injury
64. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis
65. Detection of reactivation and size variation in the regulatory region of JC virus in brain tissue
66. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picoronaviruses, but not myelin proteins
67. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination
68. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
69. Epidemiologic studies of measles; measles vaccines and subacute sclerosing panencephalitis
70. Epidemiology of subacute sclerosing panencephalitis
71. Perforin-dependent neurological injury in a viral model of multiple sclerosis
72. Coronavirus infects and causes demyelination in primate central nervous system
73. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis
74. Subacute sclerosing panencephalitis: Destruction of human brain cells by antibody and complement in an autologous system
75. Cultivation of a papovavirus-like virus from human brain with progressive multifocal leukoencephalopathy
76. Prevalence of antibodies in human sera against JC virus: An isolate from a case of progressive multifocal leukoencephalopathy
77. Uncommon morphologic features in subacute sclerosing panencephalitis (SSPE)
78. Gamma interferon is required for viral clearance from central nervous system oligodendroglia
79. Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system
80. Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis
81. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo
82. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody
83. Subacute sclerosing leuco-encephalitis. Electron microscopic finding in two cases with inclusion bodies
84. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence
85. Flow cytometric and functional analyses of CNS-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease: Evidence for a CD4+ T cell-mediated pathology
86. Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis
87. AIDS-and non-AIDS-related PML association with distinct p53 polymorphism
88. Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus
89. Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin
90. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis
91. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
92. Morphometric study of the frontal cortex in subacute sclerosing panencephalitis
93. High sensitivity detection of JC-virus DNA in postmortem brain tissue by in situ PCR
94. Tumor necrosis factor mediated myelin and oligodendroglia damage in vitro
95. Chronic nervous system demyelination in mice after JHM virus infection
96. In vivo effects of coronavirus-specific T cell clones: DTH Inducer cells prevent a lethal infection but do not inhibit virus replication
97. Characterization of mouse hepatitis virus specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain
98. Tumor necrosis factor expression during mouse hepatitis virus induced demyelination
99. Mouse hepatitis virus -specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from oligodendroglia
100. CTL effector function within the CNS requires CD4+ T cells
101. Persistent infection by mouse hepatitis virus
102. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus
103. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy
104. Subacute sclerosing leukoencephalitis: Ultrastructure of intranuclear and intracytoplasmic inclusions
105. Spontaneous encephalomyelitis of mice, a new virus disease
106. Encephalomyelitis of mice
107. Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced model of chronic inflammatory demyelination
108. Detection of HIV-1 Tat and JC nucleocapsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy
109. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination
110. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats
111. Latent measles virus infection of the hamster central nervous system
112. Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection
113. Isolation of a virus related to SV40 from patients with progressive multifocal leukoencephalopathy
114. Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus)
115. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 and identification of a non-functional, homologous protein MHV-resistant SJL/J mice
116. + T cells
117. Characterization of brain infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM
118. Primary demyelination as a non-specific consequence of a cell-mediated immune reaction
119. Acute and subacute demyelination induced by mouse hepatitis virus strain A59 in C3H mice
120. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus
121. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus
122. Reflections on the etiology and pathogenesis of subacute sclerosing panencephalitis
123. Particles resembling papovaviruses in human cerebral demyelinating disease